Depression Clinical Trial
— STAMPOfficial title:
Sleep to Activate Mood Promotion- Intervention
Verified date | April 2017 |
Source | University of Michigan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators are aiming to examine the acceptability and feasibility of a portable bright light therapy instrument to improve sleep disturbance in a preventive intervention for depression. The investigators will conduct an intervention that trials the use of bright light glasses called "re-timers" as a preventive intervention in older adults with sleep disturbance and subsyndromal symptoms of depression.
Status | Completed |
Enrollment | 12 |
Est. completion date | March 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: - 65 years of age or older - 6 or greater on the Pittsburgh Sleep Quality Index - A score of 5 to 9 on the Patient Health Questionnaire-9 Depression Scale Exclusion Criteria: - Active suicidal ideation - Presence of mania or bipolar disorder - Presence of an eye disease - Prescription of a photosensitizing medication - Having previously had eye surgery |
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan | Ann Arbor | Michigan |
Lead Sponsor | Collaborator |
---|---|
University of Michigan |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pittsburgh Sleep Quality Index | The Pittsburgh Sleep Quality Index is a validated scale which measures self-reported sleep quality based on a wide variety of questions (duration, quality, disturbances, medication, etc.) and converts them to a scale which ranges from 0 to 21 where 6 or higher denotes poor sleep quality. | two weeks after introduction of intervention | |
Primary | Patient Health Questionnaire-9 Depression Scale | The PHQ-9 Depression Scale is a validated scale ranging from 0 to 27 with higher numbers representing greater severity of depressive symptoms, based on 9 questions with each question on a scale of 0 - 3. | two weeks after introduction of intervention | |
Primary | Insomnia Severity Index Sum Scores | The Insomnia Severity Index measures insomnia severity on a scale from 0 to 28. A score of 15 or higher is indicative of clinical insomnia. | two weeks after introduction of intervention | |
Primary | Morningness-Eveningness Questionnaire | The morningness- eveningness categories represent the time of day when a person is at their peak alertness. | two weeks after introduction of intervention | |
Secondary | Actigraph Sleep Data: Minutes Asleep | mean nightly sleep duration for each of the two-week periods: baseline and intervention | daily for 4 weeks- baseline and intervention period | |
Secondary | Actigraph: Number of Awakenings | Actigraphy counts awakenings by using an accelerometer to assess motion during the night. The number of awakenings is the mean nightly number of awakenings during each of the two-week periods: baseline and intervention. | daily for 4 weeks- baseline and intervention period | |
Secondary | Actigraph: Efficiency | Sleep efficiency is calculated as a percentage reflecting the amount of time in bed spent asleep (time asleep/time in bed x 100). The mean for each of the two-week periods: baseline and intervention, is calculated. | daily for 4 weeks- baseline and intervention period | |
Secondary | Fitbit Sleep Data: Sleep Duration | mean nightly sleep duration in minutes for each of the two-week periods: baseline and intervention | daily for 4 weeks- baseline and intervention period | |
Secondary | Fitbit Sleep Data: Night Awakenings | mean nightly awakenings for each of the two week periods: baseline and intervention. Similar to the actigraph the Fitbit counts awakenings through an accelerometer which measures motion. | daily for 4 weeks- baseline and intervention period | |
Secondary | Fitbit Sleep Data: Sleep Efficiency | Sleep efficiency is calculated as a percentage reflecting the amount of time in bed spent asleep (time asleep/time in bed x 100). | daily for 4 weeks- baseline and intervention period | |
Secondary | Self-Reported Sleep Diary: Time at Which Participants go to Bed | Bed time represents the moment in time at which participants went to bed, measured on a revised clock where 6pm = 18, Midnight = 24 and 6am =30. Time between actual hours is calculated on a decimal basis, so an additional 6 minutes = .1. This revised clock is necessary in order to make means work properly in the nighttime hours. Otherwise, averaging between a 10pm bedtime and a 2am bedtime would give the impossible, inaccurate mean of being in the daytime between those two numbers. | daily for 4 weeks- baseline and intervention period to be compared | |
Secondary | Self-Reported Sleep Diary: Time at Which Participants Wake up | Wake time represents the moment in time at which participants awaken. Time between actual hours is calculated on a decimal basis so an additional 6 minutes = .1. so that 7.5 represents 7:30 a.m. and 7.8 represents 7:48 a.m. | daily for 4 weeks- baseline and intervention period to be compared | |
Secondary | Self-Reported Sleep Diary: Sleep Quality | sleep quality is a participants' mean self-report for each of the two week periods: baseline and intervention. Sleep quality is reported for each night on a scale of 0 (very poor) to 4 (very good). | daily for 4 weeks- baseline and intervention period to be compared | |
Secondary | Self-Reported Sleep Diary: Night Awakenings | mean number of night awakenings per person per night as reported in sleep diaries | daily for 4 weeks- baseline and intervention period to be compared | |
Secondary | Self-Reported Sleep Diary: Sleep Duration | nightly mean of length of sleep measured in minutes | daily for 4 weeks- baseline and intervention period to be compared |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |